Prognostic model of patients with Acute Pancreatitis based on Prothrombin Time - International Normalized Ratio to Albumin Ratio: a single-center retrospective study


Abstract

Background. The prothrombin time-international normalized ratio to albumin ratio (PTAR) is a prognostic biomarker of various diseases. However, its significance in predicting the mortality of acute pancreatitis (AP) remains unknown. We aim to investigate the association between PTAR and the 30-day outcomes in AP patients.

Methods. Data of 965 patients hospitalized with AP between January 2017 and December 2019 were retrospectively analy s ed. The baseline clinical characteristics and laboratory data were collected. Then we used Logistic regression analysis and the least absolute shrinkage and selection operator regression to develop a prognostic nomogram model based on PTAR. The predictive value and calibration ability of the nomogram were evaluated using receiver operating characteristic curve analysis and calibration plots, respectively. Bootstrap technology was used for internal validation.

Results. Overall, 43 of the 965 patients (4.5%) died. Multivariate analysis identified seven risk factors independently associated with 30-day mortality of patients with AP: Age, NE percentage, PLT, FIB, AST, UREA, and PTAR. The model based on influencing factors including PTAR has good discrimination and calibration ability in assessing 30-day mortality rate of AP patients (AUC=0.914, 95% CI:0.877-0.951). Kaplan-Meier survival curve analysis showe d that AP patients with the nomogram value > 0.082 were positive ly correlated with higher 30-day mortality (P < 0.001).

Conclusions. PTAR has good clinical value in evaluat ing 30-day prognosis of patients with AP. The model based on PTAR could be useful alone or complement other conventional measures to aid physicians in clinical treatment and decision-making.

Ask to review this manuscript

Notes for potential reviewers

  • Volunteering is not a guarantee that you will be asked to review. There are many reasons: reviewers must be qualified, there should be no conflicts of interest, a minimum of two reviewers have already accepted an invitation, etc.
  • This is NOT OPEN peer review. The review is single-blind, and all recommendations are sent privately to the Academic Editor handling the manuscript. All reviews are published and reviewers can choose to sign their reviews.
  • What happens after volunteering? It may be a few days before you receive an invitation to review with further instructions. You will need to accept the invitation to then become an official referee for the manuscript. If you do not receive an invitation it is for one of many possible reasons as noted above.

  • PeerJ does not judge submissions based on subjective measures such as novelty, impact or degree of advance. Effectively, reviewers are asked to comment on whether or not the submission is scientifically and technically sound and therefore deserves to join the scientific literature. Our Peer Review criteria can be found on the "Editorial Criteria" page - reviewers are specifically asked to comment on 3 broad areas: "Basic Reporting", "Experimental Design" and "Validity of the Findings".
  • Reviewers are expected to comment in a timely, professional, and constructive manner.
  • Until the article is published, reviewers must regard all information relating to the submission as strictly confidential.
  • When submitting a review, reviewers are given the option to "sign" their review (i.e. to associate their name with their comments). Otherwise, all review comments remain anonymous.
  • All reviews of published articles are published. This includes manuscript files, peer review comments, author rebuttals and revised materials.
  • Each time a decision is made by the Academic Editor, each reviewer will receive a copy of the Decision Letter (which will include the comments of all reviewers).

If you have any questions about submitting your review, please email us at [email protected].